R. Anand

Randomized trial of safinamide add‐on to levodopa in Parkinson's disease with motor fluctuations

Rupam Borgohain, József Attila Szász, Paolo Stanzione et al. · Movement Disorders · 2013 · 279 citations · Full text

Effects of Rivastigmine on Cognitive Function in Dementia with Lewy Bodies: A Randomised Placebo-Controlled International Study Using the Cognitive Drug Research Computerised Assessment System

Keith Wesnes, Ian G. McKeith, Roberto Ferrara et al. · Dementia and Geriatric Cognitive Disorders · 2002 · 207 citations

An efficacy and safety analysis of Exelon^® in Alzheimer’s disease patients with concurrent vascular risk factors

Vinod Kumar, R. Anand, John Messina et al. · European Journal of Neurology · 2000 · 161 citations

What Is Causing the Reduced Drug-Placebo Difference in Recent Schizophrenia Clinical Trials and What Can be Done About It?

Aaron S. Kemp, Nina R. Schooler, Amir H Kalali et al. · Schizophrenia Bulletin · 2008 · 150 citations · Full text

Placebo Response, Psychiatric Evaluation, Psychotropic Medication +16

A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer’s disease

Fiona Crawford, Melissa Freeman, John A. Schinka et al. · Neurology · 2000 · 106 citations